FDA Approves Bemotrizinol for Use in U.S. Sunscreens

The U.S. Food and Drug Administration (FDA) approved a new sunscreen ingredient on Tuesday, marking the first such authorization in more than 25 years. The agency’s decision allows for the use of bemotrizinol in over-the-counter sunscreen products sold within the United States.

This approval follows a lengthy regulatory review process for the chemical compound, which already sees widespread use in sunscreens throughout Europe and other international markets. Bemotrizinol functions as a broad-spectrum ultraviolet filter, meaning it absorbs both UVA and UVB rays to protect skin from sun damage. The FDA’s action represents a shift in domestic sunscreen regulation, as the agency had not cleared a new active ingredient for these products since the late 1990s. Manufacturers may now incorporate the ingredient into their formulations, provided they meet the agency’s established safety and efficacy standards.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: June 9, 2026

Author

GOAI